Tonix Pharmaceuticals Holding Corp. — Investor Relations & Filings

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company developing therapeutics and vaccines for human diseases. The company's pipeline addresses complex, chronic conditions in several key areas: central nervous system (CNS) disorders, immunology, infectious diseases, and rare diseases. Key CNS programs target conditions such as acute stress disorder. The immunology portfolio includes candidates for preventing organ transplant rejection, managing autoimmune conditions, and immuno-oncology. Its infectious disease efforts focus on biodefense, utilizing a live virus vaccine platform to develop vaccines for mpox and smallpox. The company is also advancing treatments for rare diseases like Prader-Willi Syndrome. All of Tonix's product candidates are investigational and have not been approved for any indication.